Cargando…
YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN
YES‐associated protein 1 (YAP1) plays a key role as a transcriptional coactivator in the Hippo tumor suppressor pathway. YAP1 is overexpressed in a variety of cancers and is considered to be encoded by a proto‐oncogene. However, the role of YAP1 remains debatable, because both gain and loss of YAP1...
Autores principales: | Guo, Liwen, Chen, Yutang, Luo, Jun, Zheng, Jiaping, Shao, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396162/ https://www.ncbi.nlm.nih.gov/pubmed/30868052 http://dx.doi.org/10.1002/2211-5463.12597 |
Ejemplares similares
-
Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1
por: Guo, Liwen, et al.
Publicado: (2021) -
Partial PTEN deletion is linked to poor prognosis in breast cancer
por: Lebok, P., et al.
Publicado: (2015) -
Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020) -
The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer
por: Shao, Ming-Tao, et al.
Publicado: (2020) -
Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer
por: Zhu, Ya-Jing, et al.
Publicado: (2017)